Jagsonpal Pharmaceuticals Ltd logo

Jagsonpal Pharmaceuticals Ltd

NSE: JAGSNPHARM BSE: 507789

₹216.15

-0.58 (0.27%)

Sun, 22 Nov 2026, 02:39 pm

mtf coin illustrationMTF 5xInvest in Jagsonpal Pharmaceuticals Ltd with 5x LeverageBuy with MTFpremium button ring illustration
Market Cap (in Cr)1427.21
PE Ratio32.46
Dividend1.16
Health TechnologyHealth Technology
Pharmaceuticals: GenericPharmaceuticals: Generic
24.5K24.5K

Jagsonpal Pharmaceuticals Share Price Live Chart

1 Day

-0.58 (0.27%)

No Result Found

Summary

  • Market Cap (in Cr)

    1371.06

  • Net Profit (in Cr)

    43.08

  • P/B

    4.50

  • Sector P/E

    51.73

  • P/E

    28.67

  • EV/EBITDA

    16.72

  • Debt/Equity (Industry)

    0.19

  • Interest Cover (Industry)

    10.63

  • ROCE (Industry)

    7.84

  • RONW (Industry)

    6.60

  • ROE

    16.69

  • ROCE

    21.83

  • Debt/Equity

    0.03

  • EPS (TTM)

    7.15

  • Dividend Yield

    1.95

  • Book Value

    36.91

  • Interest Cover

    56.84

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersSEPT 2026JUN 2026MAR 2026DEC 2025SEPT 2025
Promoters68.8169.0567.8967.3967.54
FII2.132.302.442.122.12
DII1.650.620.220.150.09
Public27.4128.0329.4530.3430.25
Government00000

Read More

Technical Analysis

RSI

38.28

MACD

-3.74

50 DMA

223.70

200 DMA

211.14

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic301.09261.04238.56220.99198.51180.94140.89
Fibonacci261.04245.74236.29220.99205.69196.24180.94
Camarilla227.10223.43219.76220.99212.42208.75205.08

Pivots Level: Classic

R3

+80.10

301.09

R2

+40.05

261.04

R1

+17.58

238.56

220.99
220.99
Pivot Point
LTP: 209.27

S1

-22.47

198.51

S2

-40.05

180.94

S3

-80.10

140.89

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    213.00

  • 20-EMA

    215.91

  • 30-EMA

    218.27

  • 50-EMA

    221.30

  • 100-EMA

    221.89

  • 200-EMA

    218.12

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
28 Oct 2026board-meetingsQuarterly Results
19 Aug 2026agm
27 Apr 2026board-meetingsAccounts, Final Dividend
27 Apr 2026dividend₹4.00 Dividend /Share04 Sept 2026
12 Mar 2026buyback
21 Jan 2026board-meetingsQuarterly Results
03 Nov 2025board-meetingsQuarterly Results
12 Aug 2025dividendFinal Dividend - Rs. - 2.512 Sept 2025
26 Jul 2025agm
06 May 2025dividend₹2.50 Dividend /Share12 Sept 2025

Read More

Peer Comparison

Jagsonpal Pharmaceuticals Ltd logo

Jagsonpal Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Laurus Labs Ltd logo

Laurus Labs Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Zydus Lifesciences Ltd logo

Zydus Lifesciences Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Read More

Jagsonpal Pharmaceuticals Ltd About

Jagsonpal Pharmaceuticals is engaged in the business of manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1978

Headquarters

CEO

Harsha Raghavan

Employees

Contact

Website icon

Website

http://www.jagsonpal.com

Email icon

Email

skmata@jagsonpal.com; cs@jagsonpal.com

Phone icon

Phone

91-011-46181100/46109900

Location icon

Location

T-210 J, Shahpur Jat, New Delhi, New Delhi, 110049

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
BLITZQUANT RESEARCH LLPbulkSell331971242.7424 Sept 2026
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkSell423870241.224 Sept 2026
BLITZQUANT RESEARCH LLPbulkBuy331971242.624 Sept 2026
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkBuy423870241.0324 Sept 2026
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkBuy608181249.7430 Jul 2026
BLITZQUANT RESEARCH LLPbulkSell329194254.4330 Jul 2026
MICROCURVES TRADING PRIVATE LIMITEDbulkSell58993625230 Jul 2026
BLITZQUANT RESEARCH LLPbulkBuy329194254.330 Jul 2026
MICROCURVES TRADING PRIVATE LIMITEDbulkBuy589936251.8230 Jul 2026
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkSell608181249.8930 Jul 2026

Read More

Jagsonpal Pharmaceuticals Ltd News

Jagsonpal Pharma Q2FY27 Results: Profit up 0.1% YoY

Jagsonpal Pharmaceuticals reported standalone net profit of ₹125.90 million for Q2FY27, a marginal rise from ₹125.74 million in Q2FY26. Revenue grew 9.3% YoY to ₹813.75 million.

28 Oct 2026

companies

Jagsonpal Pharma acquires Group Pharma wellness unit

Jagsonpal Pharmaceuticals completes acquisition of Group Pharmaceuticals' wellness portfolio for ₹23.7 crore upfront, aiming to bolster its Rx brand portfolio and reach ₹500 crore revenue.

01 Oct 2026

companies

Jagsonpal buys Wellness Portfolio for ₹46.7 cr

Jagsonpal Pharmaceuticals acquires Group Pharma's Wellness Portfolio via slump sale. Deal includes ₹23.7 cr upfront and up to ₹23.0 cr earn-out linked to FY28 sales.

23 Sept 2026

companies

Jagsonpal holds 47th AGM, appoints independent director

Jagsonpal Pharmaceuticals held its 47th AGM on September 18, 2026. Shareholders approved the FY26 financials, dividend, and the appointment of Anil Kumar Matai as an independent director.

18 Sept 2026

companies

Jagsonpal Pharma Q1 FY27 Earnings Call Recording Available

Jagsonpal Pharmaceuticals Limited has made the audio recording of its Q1 FY27 earnings conference call available on its website, held on July 30, 2026.

30 Jul 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Jagsonpal Pharmaceuticals Ltd?

    As of 22/11/2026 at 8:09 PM, Jagsonpal Pharmaceuticals Ltd shares are trading at ₹216.15.

  • 2.What is the market cap. of Jagsonpal Pharmaceuticals Ltd?

    As of 22/11/2026, the market capitalization of Jagsonpal Pharmaceuticals Ltd is ₹1,427.21 crore.

  • 3.When was Jagsonpal Pharmaceuticals Ltd founded?

    Jagsonpal Pharmaceuticals Ltd was founded in 1978.

  • 4.What are the P/E and P/B ratios of Jagsonpal Pharmaceuticals Ltd?

    As of 22/11/2026, Jagsonpal Pharmaceuticals Ltd has a P/E ratio of 32.46 and a P/B ratio of 4.50.

  • 5.How can I buy shares of Jagsonpal Pharmaceuticals Ltd?

    You can buy shares of Jagsonpal Pharmaceuticals Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.What is the shareholding pattern of Jagsonpal Pharmaceuticals Ltd?

    As of September,2026, promoters hold 68.81% in Jagsonpal Pharmaceuticals Ltd, while FIIs, DIIs and public shareholders hold 2.13%, 1.65% and 27.41%, respectively.

  • 7.Does Jagsonpal Pharmaceuticals Ltd pay dividends?

    Yes, Jagsonpal Pharmaceuticals Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹₹4.00 Dividend /Share per share.

  • 8.What is the dividend yield of Jagsonpal Pharmaceuticals Ltd?

    As of 22 November, 2026, the dividend yield of Jagsonpal Pharmaceuticals Ltd stands at 1.16%.

  • 9.What are the latest financial results of Jagsonpal Pharmaceuticals Ltd?

    For the financial year ended March 2025, Jagsonpal Pharmaceuticals Ltd reported revenue of ₹269.00 crore and a net profit of ₹55.36 crore.

  • 10.What is the Stock symbol of Jagsonpal Pharmaceuticals Ltd?

    JAGSNPHARM is the stock symbol of Jagsonpal Pharmaceuticals Ltd.

  • 11.Who is the CEO of Jagsonpal Pharmaceuticals Ltd?

    The CEO of Jagsonpal Pharmaceuticals Ltd is Harsha Raghavan.

pocketful logo lightpocketful logo dark
PricingBecome a Partner
search icon
/

No results for ''

Popular search

  • popular search iconSuzlon Energy Ltd
  • popular search iconIndian Railway Finance Corporation Ltd
  • popular search iconTata Motors Ltd
  • popular search iconTata Steel Ltd
  • popular search iconRail Vikas Nigam Ltd

Recent search

      Log In
      search icon

      No results for ‘’

        Popular search

        • popular search iconSuzlon Energy Ltd
        • popular search iconIndian Railway Finance Corporation Ltd
        • popular search iconTata Motors Ltd
        • popular search iconTata Steel Ltd
        • popular search iconRail Vikas Nigam Ltd
        • popular search iconReliance Industries Ltd
        pocketful logo lightpocketful logo dark
        • Pricing
        • Become a Partner
        Log In
        • home icon
        • arrow iconstocks
        • arrow iconjagsonpal pharmaceuticals ltd
        • Overview
        • Financials
        • Ratios
        • shareholding
        • Technical Analysis
        • Corporate Actions
        • Peer Comparison
        • About
        • Deals
        • News
        • FAQs

        Open Your Free Demat Account Now!

        Step into a world of zero fees and limitless opportunities!

        pocketful logo
        • Quick Links

          • Open Demat Account
          • Pocketful Web
          • Pocketful App
          • Pricing
          • Authorised Person
          • Pocketful Calculators
          • Compliance Links
        • Pages

          • Tools
          • Blogs
          • ETF Screener
          • IPO
          • ETF
          • Bonds
          • Index Heat Map
        • Products

          • Stocks
          • Commodity
          • Subscription
          • Free Stock Screener
          • Pocketful GPT
          • MTF
          • Mutual Funds
        • Company

          • About us
          • Contact us
          • Terms and Conditions
          • Policies & Procedures
          • Privacy Policy
          • Disclosure
          • Careers
        • Socials

          • Facebook iconFacebook
          • Twitter iconTwitter
          • Instagram iconInstagram
          • LinkedIn iconLinkedIn
          • Youtube iconYoutube

        2022-25 Pocketful. All rights reserved, Built with in India

        Version -5.76

        app image 1app image 2

        Stocks:

        AllABCDEFGHIJKLMNOPQRSTUVWXYZ

        Explore

        Calculators
        Popular Calculators
        Group Stocks
        Asset Management Companies
        Popular Stocks
        Indian Indices
        Sector Wise Stocks
        IPO
        Share Market
        Best MF Schemes
        Platforms
        Resources
        Gold Rates in Top Cities
        Silver Rates in Top Cities

        Others:

        NSEBSECDSLNSDLSEBIMCXMSEINCDEXNSE IFSCINDIA INXAccount Closure FormDP Investor CharterBroker Investor Charter

        Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800